Cure Pharmaceutical Holding Corp. (CURR)
NASDAQ
Real-time Data
01:30 PM
Day's Range
3.3052 wk Range
1.31Overview - CURR - Cure Pharmaceutical Holding Corp.
Key Statistics
Valuation
Enterprise Value
394.23M
P/E (Trailing)
‪-11.73‬
P/E (Forward)
‪-14.20‬
PEG Ratio
‪-14.20‬
Price / Sales (TTM)
‪10.54‬
EV / EBITDA
‪-66.81‬
Profitability
Gross Margin
‪42.74%‬
Profit Margin
‪-48.74%‬
Operating Margin
‪-46.54%‬
Return on Assets
‪-4.53%‬
Return on Equity
‪-98.81%‬
Ownership
Shares Outstanding
76.61M
Float
36.50M
Short % of Shares Outstanding
‪1.95%‬
Held by Insiders
‪63.34%‬
Held by Institutions
‪0.91%‬
Price stats
Beta
‪0.12‬
50-Day Avg
‪3.19‬
200-Day Avg
‪2.71‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
1 analysts
Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - CURR - Cure Pharmaceutical Holding Corp.
Peers - CURR - Cure Pharmaceutical Holding Corp.
Peer Comparison
Compared with companies in Software - Application listed on NASDAQ.
- CUCURRNASDAQCure Pharmaceutical Holding Corp.394.10MMarket Cap+52.17%52-week change-12.27P/E (Trailing)‪-48.74%‬Profit Margin
- ADPNASDAQAutomatic Data Processing Inc.112.42BMarket Cap-7.36%52-week change25.64P/E (Trailing)‪20.10%‬Profit Margin
- ADBENASDAQAdobe Inc.109.81BMarket Cap-30.45%52-week change15.62P/E (Trailing)‪28.68%‬Profit Margin
- INTUNASDAQIntuit Inc.101.18BMarket Cap-82.96%52-week change22.37P/E (Trailing)‪21.90%‬Profit Margin
- CDNSNASDAQCadence Design Systems Inc87.85BMarket Cap-10.25%52-week change63.30P/E (Trailing)‪23.60%‬Profit Margin
- DDOGNASDAQDatadog, Inc. Class A Common Stock81.06BMarket Cap+43.14%52-week change480.86P/E (Trailing)‪4.47%‬Profit Margin
- ADSKNASDAQAutodesk Inc.53.71BMarket Cap-11.02%52-week change37.03P/E (Trailing)‪19.48%‬Profit Margin
Profile Summary - CURR - Cure Pharmaceutical Holding Corp.
About
Cure Pharmaceutical Holding Corp. is a biopharmaceutical company focused on the development and commercialization of innovative drug delivery systems. It aims to improve patient adherence and experience by providing new methods for drug delivery, such as oral thin films and transdermal systems. Cure Pharmaceutical's…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
